Skip to main content
Premium Trial:

Request an Annual Quote

DNA Script: Patrick Eimerman, John Luckey

Patrick Eimerman has been named global head of marketing and John Luckey has been appointed as VP for product development at DNA Script. Both will be based at the company's new US office. Eimerman joins DNA Script from Illumina, where he held senior sales and marketing roles. Prior to that, he was director of sales at GenomOncology and worked at Roche NimbleGen and DNA2.0. He holds a PhD in microbiology and immunology from Stanford University and a BS in bacteriology from the University of Wisconsin-Madison. Luckey comes to DNA Script from Thrive Bioscience, where he was VP of engineering and manufacturing. Before that, he held development roles at RainDance Technologies, Pathogenetix, Roche NimbleGen, and OpGen. Luckey holds PhD and MBA degrees from the University of Wisconsin-Madison and a BS from Stanford University.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.